1. Michel A. J. Georges 比利时 University of Liège 2006沃尔夫农业奖;2013美国科学院院士 Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease s..
2. 麦康森 中国 中国海洋大学 中国工程院院士 Vitamin D3 deficiency induced intestinal inflammatory response of turbot through nuclear ..
3. Cho, Judy H. 美国 Icahn School of Medicine at Mount Sinai 2020美国医学院院士 Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease s..
4. Daly, Mark J. 美国 Massachusetts General Hospital 2017美国医学院院士 Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease s..
5. Cho, Judy H. 美国 Icahn School of Medicine at Mount Sinai 2020美国医学院院士 Constrictive and Hypertrophic Strictures in Ileal Crohn's Disease
6. Douglas A. Lauffenburger 美国 Massachusetts Institute of Technology 2001美国工程院院士 The colonic epithelium plays an active role in promoting colitis by shaping the tissue cytokine prof..
7. 陈志南 中国 空军军医大学 中国工程院院士 TNFAIP3-DEPTOR complex regulates inflammasome secretion through autophagy in ankylosing spondylitis ..
8. Alberto,Martin 加拿大 University of Toronto Suppression of Class Switch Recombination to IgA by RASA2 and RASA3 through Inhibition of TGF-b Sign..
9. Marc,Ferrante 比利时 Katholieke Universiteit Leuven(KU Leuven) Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a..
10. Geert R,D'Haens 荷兰 University of AMSTERDAM Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a..
11. Vipul,Jairath 加拿大 University of Western Ontario Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a..
12. Silvio,Danese 意大利 Humanitas University Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a..
13. 陈旻湖 中国 中山大学 主任医师/教授 Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a..
14. Subrata,Ghosh 英国 University of BIRMINGHAM Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a..
15. Britta,Siegmund 德国 Charite - Medical University of Berlin Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a..
16. Bruce E,Sands 美国 Icahn School of Medicine at Mount Sinai Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a..
17. 孙毅 中国 浙江大学 教授 Protein neddylation and its role in health and diseases
18. 林欣 中国 清华大学 Neddylation Regulation of Immune Responses
19. 孙毅 中国 浙江大学 教授 Neddylation Regulation of Immune Responses
20. Paolo,Lionetti 意大利 University of Florence Gene expression profiling in white blood cells reveals new insights into the molecular mechanisms of..